Can Oncol Nurs J. 1998 Nov;8(4):262-4.
In determining whether or not to undergo early detection tests (PSA and DRE), men must weight the possibility of early diagnosis and treatment of potentially aggressive prostate cancer against the limitation of these tests and decisions they will be faced with regarding treatment choices, effectiveness and side effects. The Prostate Cancer Alliance recommends that men 50 years of age or older talk to their physicians and inform themselves about the benefits and risks of early detection testing using PSA and DRE in order to make an informed decision about whether to have the tests. Men in higher risk categories (those with a family history of the disease or with an African Canadian ancestry) should consider this recommendation starting at age 40. Extensive information is available on these matters. Men should request such information from their family physician or their urologist and consult any or all of the groups sponsoring this message.
在决定是否接受早期检测测试（前列腺特异抗原检测和直肠指检）时，男性必须权衡早期诊断和治疗潜在侵袭性前列腺癌的可能性与这些检测的局限性，以及他们将面临的有关治疗选择、疗效和副作用的决策。前列腺癌联盟建议，50岁及以上的男性应与医生沟通，并了解使用前列腺特异抗原检测和直肠指检进行早期检测的益处和风险，以便就是否进行检测做出明智的决定。高风险类别的男性（有家族病史或有非洲裔加拿大血统的人）应从40岁开始考虑这一建议。关于这些问题有大量信息可供获取。男性应向其家庭医生或泌尿科医生索取此类信息，并咨询发起本信息的任何或所有团体。
